The UCLA multidisciplinary team reaffirms its commitment to participate in and lead the clinical research studies of the Children's Cancer Group (CCG). The addition of affiliates in Albany and Las Vegas will continue to strengthen patient accrual. Growth of the core program at the UCLA Medical Center will focus on clinical and basic research in the supportive academic environment of the UCLA School of Medicine, the UCLA-Jonsson Comprehensive Cancer Center, and the Molecular Biology Institute. Our clinical research program has a long history of leadership; we shall continue to lead in the areas of hematologic neoplasms and stem cell transplantation and, with the recruitment of a new clinical director, Dr. Malogolowkin, we have expanded our area of study leadership into the solid tumors and new agents. Other new UCLA recruits will open up additional areas of research with CCG, including new approaches to the diagnosis of round cell tumors, metabolic identification of high-risk low-grade astrocytomas, diagnostic application of fluorescence in-situ hybridization, cord blood stem cell transplants and assessment of long-term outcome after treatment of brain tumors. The melding of a mature, active and diverse clinical research program with a productive thrust in translational and outcomes research will be an asset to CCG in the coming years.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
2U10CA027678-20
Application #
2719559
Study Section
Subcommittee G - Education (NCI)
Program Officer
Smith, Malcolm M
Project Start
1980-12-01
Project End
2002-11-30
Budget Start
1998-12-11
Budget End
1999-11-30
Support Year
20
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Pediatrics
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Neudorf, Steven; Sanders, Jean; Kobrinsky, Nathan et al. (2004) Allogeneic bone marrow transplantation for children with acute myelocytic leukemia in first remission demonstrates a role for graft versus leukemia in the maintenance of disease-free survival. Blood 103:3655-61
Seitzman, Robin L; Glover, Dorie A; Meadows, Anna T et al. (2004) Self-concept in adult survivors of childhood acute lymphoblastic leukemia: a cooperative Children's Cancer Group and National Institutes of Health study. Pediatr Blood Cancer 42:230-40
Shamberger, Robert C; LaQuaglia, Michael P; Gebhardt, Mark C et al. (2003) Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy. Ann Surg 238:563-7; discussion 567-8
Davies, Stella M; Bhatia, Smita; Ross, Julie A et al. (2002) Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia. Blood 100:67-71
Lange, Beverly J; Bostrom, Bruce C; Cherlow, Joel M et al. (2002) Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 99:825-33
Ou, Shu Xiao; Han, Dehui; Severson, Richard K et al. (2002) Birth characteristics, maternal reproductive history, hormone use during pregnancy, and risk of childhood acute lymphocytic leukemia by immunophenotype (United States). Cancer Causes Control 13:15-25
Cairo, M S; Krailo, M D; Morse, M et al. (2002) Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate ('Orange') in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer group report. Leukemia 16:594-600
Wells, R J; Arthur, D C; Srivastava, A et al. (2002) Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's Cancer Group Study 213. Leukemia 16:601-7
Meyers, P A; Krailo, M D; Ladanyi, M et al. (2001) High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis. J Clin Oncol 19:2812-20
Kammen, B F; Matthay, K K; Pacharn, P et al. (2001) Pulmonary metastases at diagnosis of neuroblastoma in pediatric patients: CT findings and prognosis. AJR Am J Roentgenol 176:755-9

Showing the most recent 10 out of 21 publications